SCHEMBL30195683

SCHEMBL30195683

COc1cc(C=O)ccc1OP(=O)=O

nearest known ligand 0.75

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 12/20 0.75
▸ TSHR P16473 1/20 0.75
▸ FDPS P14324 1/20 0.64
▸ TTR P02766 1/20 0.58
▸ HPGD P15428 3/20 0.58
▸ AOX1 Q06278 1/20 0.58
▸ TRIM24 O15164 1/20 0.58
▸ ALDH5A1 P51649 1/20 0.58
▸ ABAT P80404 1/20 0.58
▸ TDP1 Q9NUW8 1/20 0.58
▸ TRIM33 Q9UPN9 1/20 0.58
▸ MAPT P10636 5/20 0.54
▸ SMN1; SMN2 Q16637 5/20 0.51
▸ HTT P42858 2/20 0.51
▸ LMNA P02545 1/20 0.51
▸ NPSR1 Q6W5P4 1/20 0.51
▸ KDM4E B2RXH2 2/20 0.50
▸ NPC1 O15118 1/20 0.49
▸ RAB9A P51151 1/20 0.49
▸ ALDH1A3 P47895 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
3,4-Dimethoxybenzaldehyde SCHEMBL29364994 0.86 ALDH1A1 (1.00) ALDH1A1TSHRFDPSTTRHPGD
3,4-Dimethoxybenzaldehyde SCHEMBL25202 0.86 ALDH1A1 (1.00) ALDH1A1TSHRFDPSTTRHPGD
3,4-Dimethoxybenzaldehyde SCHEMBL1330962 0.86 ALDH1A1 (1.00) ALDH1A1TSHRFDPSTTRHPGD
3,4-Dimethoxybenzaldehyde SCHEMBL5308959 0.86 ALDH1A1 (1.00) ALDH1A1TSHRFDPSTTRHPGD
SCHEMBL29209125 0.86 ALDH1A1 (0.70) ALDH1A1TSHRFDPSTTRHPGD
3,4-Dimethoxybenzaldehyde SCHEMBL29624454 0.84 ALDH1A1 (0.96) ALDH1A1TSHRFDPSTTRHPGD
3,4-Dimethoxybenzaldehyde SCHEMBL28205798 0.84 ALDH1A1 (0.96) ALDH1A1TSHRFDPSTTRHPGD
SCHEMBL15540340 0.82 ALDH1A1 (0.84) ALDH1A1TSHRFDPSTTRHPGD
SCHEMBL1869030 0.82 ALDH1A1 (0.84) ALDH1A1TSHRFDPSTTRHPGD
3,4-Dimethoxybenzaldehyde SCHEMBL28147472 0.82 ALDH1A1 (0.92) ALDH1A1TSHRFDPSTTRHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12429489-B2 Method for determining the lipid content of extracellular vesicles SEMMELWEIS EGYETEM (HU) 2025-09-30 — — US claimed
EP-3645731-B1 A PROCESS FOR THE PRODUCTION OF LIPIDS FROM BIOMASS DERIVED FROM GUAYULE PLANTS ENI SPA (IT) 2026-01-14 — — EP disclosed
EP-4674972-A1 METHOD OF PRODUCING A FATTY ESTER FROM MICROALGAE Institut National de la Recherche pour l'Agriculture, l'Alimentation et l'Environnement (FR) 2026-01-07 — — EP disclosed
US-12429489-B2 Method for determining the lipid content of extracellular vesicles SEMMELWEIS EGYETEM (HU) 2025-09-30 — — US disclosed
US-20250207158-A1 FERMENTATION PROCESS FOR THE PRODUCTION OF LIPIDS FROM OLEAGINOUS YEASTS VERSALIS SPA (IT) 2025-06-26 — — US disclosed
WO-2025073824-A1 PHOSPHOLIPID CONJUGATES AND THEIR USES AARHUS UNIVERSITET (DK) 2025-04-10 — — WO disclosed
EP-4499853-A1 FERMENTATION PROCESS FOR THE PRODUCTION OF LIPIDS FROM OLEAGINOUS YEASTS Versalis S.p.A. (IT) 2025-02-05 — — EP disclosed
CN-118086059-A Method for improving grease yield and nitrogen absorption capacity of xanthomonas campestris 武汉轻工大学 2024-05-28 — — CN disclosed
US-20230413823-A1 HYPERLOADED YEAST CELL WALL PARTICLE AND USES THEREOF UNIV MASSACHUSETTS (US) 2023-12-28 — — US disclosed
CN-110832082-B Process for the production of lipids from biomass derived from guayule plants 埃尼股份公司 2023-12-19 — — CN disclosed
WO-2023230324-A1 HYPERLOADED YEAST CELL WALL PARTICLE AND USES THEREOF UNIVERSITY OF MASSACHUSETTS (US) 2023-11-30 — — WO disclosed
US-20230364156-A1 TREATING OF NEUROLOGICAL DISORDERS USING EXTRACELLULAR VESICLES RELEASED BY HUMAN INDUCED PLURIPOTENT STEM CELL DERIVED NEURAL STEM CELLS NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2023-11-16 — — US disclosed
US-20230340597-A1 BIOMARKER PANELS, SYSTEMS, AND METHODS FOR RISK STRATIFICATION OF A SUBJECT FOR ALZHEIMER'S DISEASE URVOGELBIO PRIVATE LIMITED (IN) 2023-10-26 — — US disclosed
WO-2023180925-A1 FERMENTATION PROCESS FOR THE PRODUCTION OF LIPIDS FROM OLEAGINOUS YEASTS VERSALIS S.P.A. (IT) 2023-09-28 — — WO disclosed
CN-116268233-A Total nutrient red colored Hunting stink bug artificial feed and preparation method thereof 中国烟草总公司海南省公司 2023-06-23 — — CN disclosed
CN-116209667-A Vanillin-derived flame retardant monomers, resins, prepolymers and polymers 多伦多大学管理委员会 2023-06-02 — — CN disclosed
CN-111655838-B Variants of oleaginous yeast and their use for lipid production 维尔萨利斯股份公司 2023-05-02 — — CN disclosed
CN-115807052-A Method for screening high-yield DHA schizochytrium limacinum and application thereof 华中农业大学 2023-03-17 — — CN disclosed
WO-2023003204-A1 ANTI-OBESITY COMPOSITION CONTAINING ROSA DAVURICA EXTRACT AS ACTIVE INGREDIENT 스노우화이트팩토리(주) 2023-01-26 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230413823-A1 HYPERLOADED YEAST CELL WALL PARTICLE AND USES THEREOF NSF, SACM1L, ERG28 ALDH1A1 4783/4885TSHR 4710/4885FDPS 1611/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback